1. Home
  2. TAYD vs PBYI Comparison

TAYD vs PBYI Comparison

Compare TAYD & PBYI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TAYD
  • PBYI
  • Stock Information
  • Founded
  • TAYD 1955
  • PBYI 2010
  • Country
  • TAYD United States
  • PBYI United States
  • Employees
  • TAYD N/A
  • PBYI N/A
  • Industry
  • TAYD Industrial Machinery/Components
  • PBYI Biotechnology: Pharmaceutical Preparations
  • Sector
  • TAYD Industrials
  • PBYI Health Care
  • Exchange
  • TAYD Nasdaq
  • PBYI Nasdaq
  • Market Cap
  • TAYD 154.2M
  • PBYI 171.7M
  • IPO Year
  • TAYD N/A
  • PBYI N/A
  • Fundamental
  • Price
  • TAYD $47.78
  • PBYI $4.56
  • Analyst Decision
  • TAYD
  • PBYI Strong Buy
  • Analyst Count
  • TAYD 0
  • PBYI 1
  • Target Price
  • TAYD N/A
  • PBYI $7.00
  • AVG Volume (30 Days)
  • TAYD 12.0K
  • PBYI 980.5K
  • Earning Date
  • TAYD 09-26-2025
  • PBYI 11-06-2025
  • Dividend Yield
  • TAYD N/A
  • PBYI N/A
  • EPS Growth
  • TAYD 11.24
  • PBYI 434.29
  • EPS
  • TAYD 2.87
  • PBYI 0.97
  • Revenue
  • TAYD $46,292,725.00
  • PBYI $238,062,000.00
  • Revenue This Year
  • TAYD $10.81
  • PBYI N/A
  • Revenue Next Year
  • TAYD $8.37
  • PBYI N/A
  • P/E Ratio
  • TAYD $16.72
  • PBYI $4.75
  • Revenue Growth
  • TAYD 3.83
  • PBYI 8.63
  • 52 Week Low
  • TAYD $29.50
  • PBYI $2.25
  • 52 Week High
  • TAYD $64.50
  • PBYI $6.07
  • Technical
  • Relative Strength Index (RSI)
  • TAYD 53.35
  • PBYI 47.28
  • Support Level
  • TAYD $46.99
  • PBYI $4.93
  • Resistance Level
  • TAYD $49.42
  • PBYI $5.22
  • Average True Range (ATR)
  • TAYD 2.23
  • PBYI 0.32
  • MACD
  • TAYD 0.08
  • PBYI -0.10
  • Stochastic Oscillator
  • TAYD 43.06
  • PBYI 7.37

About TAYD Taylor Devices Inc.

Taylor Devices Inc is involved in the design, development, manufacture, and marketing of shock absorption, rate control, and energy storage devices for use in various types of machinery, equipment, and structures. The company's product line includes Seismic dampers, Fluidicshoks, Crane and industrial buffers, Self-adjusting shock absorbers, Liquid die springs, and Vibration Dampers. Its products are generally used to absorb, control, or mitigate the motion of masses caused by earthquakes or explosions. The company markets its products to various industries such as industrial, steel mills, buildings, bridges, aerospace, defense, and automotive industries.

About PBYI Puma Biotechnology Inc

Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis resulting into apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.

Share on Social Networks: